Filler, In-Vivo and Research - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Filler

In-Vivo

Research

SkinVive by Juvéderm: The New Dermal Filler Coming to the US

XTalks

MAY 22, 2023

“This unique product is a result of our vast experience in hyaluronic acid science and complements our current collection of hyaluronic acid products, with the Juvéderm collection of fillers and SkinMedica topicals.” . “Skin quality is among the top concerns my patients express when seeking aesthetic treatments. .

Filler

Filler FDA Approval Dermatology In-Vivo

TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainOn-schedule completion of enrollment despite COVID-19 pandemic; unique trial design evaluates safety and efficacy of single & repeat doses

The Pharma Data

DECEMBER 27, 2020

In these unprecedented times, we are especially grateful for the dedication of our research site staff and trial participants, whose commitment to EXCELLENCE facilitated the advancement of our lead program,” said George Yeh, President of TLC. SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec. About TLC599.

Trials

Trials Clinical Trials Clinical Trials Containment

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

SkinVive by Juvéderm: The New Dermal Filler Coming to the US

TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainOn-schedule completion of enrollment despite COVID-19 pandemic; unique trial design evaluates safety and efficacy of single & repeat doses

Webinars

Stay Connected